Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response
{{output}}
Protein arginine methyltransferase 1 (PRMT1) dysregulation is frequently observed in various human cancers, including breast cancer. However, the antitumor efficacy of PRMT1 inhibitors remains limited in the treatment of breast cancer. Here, we propose a dual ... ...
